Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CORAL LAB. vs NATCO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CORAL LAB. NATCO PHARMA CORAL LAB./
NATCO PHARMA
 
P/E (TTM) x 14.6 13.3 109.2% View Chart
P/BV x 0.9 3.5 24.5% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 CORAL LAB.   NATCO PHARMA
EQUITY SHARE DATA
    CORAL LAB.
Mar-23
NATCO PHARMA
Mar-23
CORAL LAB./
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs368847 43.5%   
Low Rs217502 43.2%   
Sales per share (Unadj.) Rs218.8148.4 147.5%  
Earnings per share (Unadj.) Rs18.139.2 46.1%  
Cash flow per share (Unadj.) Rs24.248.2 50.2%  
Dividends per share (Unadj.) Rs05.50 0.0%  
Avg Dividend yield %00.8 0.0%  
Book value per share (Unadj.) Rs433.6267.1 162.3%  
Shares outstanding (eoy) m3.57182.47 2.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.34.5 29.4%   
Avg P/E ratio x16.217.2 94.2%  
P/CF ratio (eoy) x12.114.0 86.6%  
Price / Book Value ratio x0.72.5 26.7%  
Dividend payout %014.0 0.0%   
Avg Mkt Cap Rs m1,045123,049 0.8%   
No. of employees `000NANA-   
Total wages/salary Rs m1114,867 2.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m78127,071 2.9%  
Other income Rs m691,285 5.4%   
Total revenues Rs m85028,356 3.0%   
Gross profit Rs m399,117 0.4%  
Depreciation Rs m221,638 1.3%   
Interest Rs m3145 2.3%   
Profit before tax Rs m828,619 1.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m181,466 1.2%   
Profit after tax Rs m647,153 0.9%  
Gross profit margin %4.933.7 14.6%  
Effective tax rate %21.617.0 127.3%   
Net profit margin %8.326.4 31.2%  
BALANCE SHEET DATA
Current assets Rs m1,23530,003 4.1%   
Current liabilities Rs m1196,831 1.7%   
Net working cap to sales %143.085.6 167.0%  
Current ratio x10.44.4 237.2%  
Inventory Days Days23163 363.7%  
Debtors Days Days1,094115 948.0%  
Net fixed assets Rs m50826,571 1.9%   
Share capital Rs m36365 9.8%   
"Free" reserves Rs m1,51248,373 3.1%   
Net worth Rs m1,54848,738 3.2%   
Long term debt Rs m00-   
Total assets Rs m1,74356,574 3.1%  
Interest coverage x25.360.4 41.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.40.5 93.6%   
Return on assets %3.912.9 30.2%  
Return on equity %4.214.7 28.4%  
Return on capital %5.518.0 30.8%  
Exports to sales %92.10-   
Imports to sales %010.2 0.0%   
Exports (fob) Rs m719NA-   
Imports (cif) Rs mNA2,772 0.0%   
Fx inflow Rs m71917,256 4.2%   
Fx outflow Rs m132,772 0.5%   
Net fx Rs m70614,484 4.9%   
CASH FLOW
From Operations Rs m1278,491 1.5%  
From Investments Rs m-26-4,771 0.5%  
From Financial Activity Rs m-64-3,630 1.8%  
Net Cashflow Rs m36208 17.4%  

Share Holding

Indian Promoters % 20.0 49.7 40.2%  
Foreign collaborators % 51.5 0.0 -  
Indian inst/Mut Fund % 0.1 25.0 0.6%  
FIIs % 0.1 13.7 1.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 28.5 50.3 56.7%  
Shareholders   4,005 207,571 1.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CORAL LAB. With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on CORAL LAB. vs Natco Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

CORAL LAB. vs Natco Pharma Share Price Performance

Period CORAL LAB. Natco Pharma S&P BSE HEALTHCARE
1-Day -3.68% -2.11% 1.18%
1-Month 2.65% -3.19% -0.75%
1-Year 65.07% 72.80% 61.82%
3-Year CAGR 4.80% 4.96% 18.16%
5-Year CAGR 3.18% 10.96% 19.79%

* Compound Annual Growth Rate

Here are more details on the CORAL LAB. share price and the Natco Pharma share price.

Moving on to shareholding structures...

The promoters of CORAL LAB. hold a 71.5% stake in the company. In case of Natco Pharma the stake stands at 49.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of CORAL LAB. and the shareholding pattern of Natco Pharma.

Finally, a word on dividends...

In the most recent financial year, CORAL LAB. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Natco Pharma paid Rs 5.5, and its dividend payout ratio stood at 14.0%.

You may visit here to review the dividend history of CORAL LAB., and the dividend history of Natco Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.